Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
نویسنده : Jin Ju Kim , Jang , Hyeon Ah Lee , , Mi Ri Park , Hye Won Kook , Seung-Tae Lee , Jong Rak Choi , Yoo Hong Min , Saeam Shin , and June-Won Cheong .
تاریخ انتشار : 1402/02/05
AML is a heterogeneous disease, and despite intensive therapy, recurrence
is still high in AML patients who achieve the criterion for cytomorphologic remission (residual tumor burden [measurable residual disease, MRD]<5%). This study aimed to develop a targeted next-generation sequencing (NGS) panel to detect MRD in AML patients
and validate its performance.
reference : Iranian Association of Clinical Laboratory Doctors